DTI
0.023
360%
AFA
0.1
-71.4%
MRD
0.056
75%
ROG
0.003
-40%
ERA
0.003
50%
KEY
0.063
-36.4%
JAV
0.003
50%
GLA
0.016
-33.3%
EMT
0.007
40%
SPX
0.002
-33.3%
AUR
0.027
35%
FBR
0.003
-25%
C7A
0.004
33.3%
BDG
0.049
-24.6%
IMA
0.08
33.3%
TAS
0.019
-24%
VML
0.3
30.4%
TRE
0.3
-22.1%
PHO
0.125
28.9%
TM1
0.15
-18.9%
SFX
0.125
26.3%
DY6
0.13
-18.8%
AR3
0.265
26.2%
ILT
0.38
-18.3%
BVR
0.52
25.3%
CRI
0.028
-17.6%
FRX
0.012
20%
PVT
0.019
-17.4%
STG
0.43
19.4%
OVT
0.005
-16.7%
BB1
0.78
19.1%
PGY
0.005
-16.7%
AU1
0.025
19%
RR1
0.01
-16.7%
CLA
0.013
18.2%
TFL
0.005
-16.7%
UNT
0.013
18.2%
8IH
0.026
-16.1%
8CO
0.033
17.9%
SCN
0.026
-16.1%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

BlinkLab (ASX:BB1): Creating better tests to diagnose various neurodevelopmental conditions

Ahead of appearing at the Spark+ Australian Equities Day in Singapore, BlinkLab’s (ASX:BB1) Non-Executive Chairman Brian Leedman speaks with The Stock Network’s Lel Smits about:

📱 BlinkLab’s autism diagnostic test, technology development and near priorities
📱 Technology features and potential commercial outcomes

Watch the full interview ⚡️ https://www.youtube.com/watch?v=t7z7g9kUTvA
Register to attend Australian Equities Day: https://www.eventbrite.sg/e/spark-plus-australian-equities-day-tickets-939180011697